Integra LifeSciences Corp (IART): Kapitalisasi marang pendapatan

Simbol lan logo merek Integra LifeSciences Corp (IART)

Despite a conservative pace of developing new biomaterials, Integra LifeSciences maintains its status as a global leader in neurosurgery due to physician trust in the Codman brand. The company's rolling P/S reflects market expectations, with the current level sitting around 0.70. The business development vector relies on the implementation of breakthrough methods for nerve fiber restoration and tissue healing in operating rooms.

IART Multiplikator P/S Integra LifeSciences Corp (04.07.2022 - 13.11.2026)

Rincian analitis perusahaan Integra (IART)

- rega saham lan konsensus proyeksi valuasi:
Analisis umum perusahaan:IART integralife.com
Barang utama Integra LifeSciences

To identify fundamental sector leaders, the analyst compares the asset's market value with its actual sales volume, assessing the premium for every dollar of revenue. This market cap-to-revenue ratio reflects the resilience of Integra LifeSciences (IART), whose positions in neurosurgery and tissue regeneration ensure a stable cash flow even during periods of production standard modernization, confirming the reliability of the valuation on this chart.

Pesaing Integra LifeSciences

BSX (bostonscientific.com) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Edwards Lifesciences Corporation EW|RMD - Kapitalisasi marang pendapatan|OmniPod - Multiplikator P/S|Rega marang dodolan Zimmer Biomet Holdings|COO: Multiplikator P/S|Rasio kapitalisasi marang pendapatan ALGN|GMED (Globus Medical) - Multiplikator P/S|TransMedics Group Inc (TMDX) - Koefisien rega marang pendapatan|Multiplikator P/S ATEC|Kapitalisasi marang pendapatan Artivion Corp AORT|Multiplikator P/S ENOV (Enovis Corporation)|Multiplikator P/S establishmentlabs.com ESTA|BBNX - Rasio rega marang pendapatan|IRMD: Rasio rega marang pendapatan|EMBC (Embecta Inc.) - Kapitalisasi marang pendapatan|Tandem Corp - Rasio kapitalisasi pasar marang pendapatan|AXGN (AxoGen, Inc.) - Multiplikator P/S|Rega marang dodolan si-bone.com SIBN|Rasio rega marang pendapatan Orthofix (OFIX)|Bioventus Inc (BVS) - Multiplikator rega marang pendapatan|OrthoPediatrics - Kapitalisasi marang pendapatan|Multiplikator P/S Treace Corp TMCI|Strata Critical Medical Inc - Multiplikator P/S|Koefisien rega marang pendapatan carlsmed.com CARL|RxSight (RXST) - Rasio rega marang pendapatan|Rasio rega marang dodolan CLPT (ClearPoint Neuro)|Rasio rega marang pendapatan Stereotaxis Corp|Kapitalisasi marang pendapatan Neuronetics, Inc (STIM)|Multiplikator P/S SGHT|OBIO - Rega marang dodolan|Rasio rega marang pendapatan Anika Therapeutics, Inc. ANIK|NSPR: Rasio kapitalisasi marang pendapatan|ZJYL: Kapitalisasi marang pendapatan|Vivani Medical, Inc. - Kapitalisasi marang volume dodolan|XTNT: Multiplikator P/S|NMTC - Koefisien rega marang pendapatan|Rasio rega marang pendapatan Modular Medical Inc|Rasio kapitalisasi marang pendapatan MYO (Myomo Inc.)|Kapitalisasi marang pendapatan COCH (Envoy Medical, Inc)|Kapitalisasi marang volume dodolan VVOS|Multiplikator P/S NVNO (enVVeno Medical)|Sintx Technologies Inc (SINT) - Rega marang dodolan|Tenon Medical - Multiplikator P/S|Multiplikator rega marang pendapatan ReWalk Robotics (LFWD)|autonomix.com (AMIX) - Rasio rega marang pendapatan|INVO Fertility Corp - Rasio kapitalisasi pasar marang pendapatan|BBLG (Bone Biologics) - Multiplikator P/S|Multiplikator P/S axonics.com|Kapitalisasi marang pendapatan BIOL (BIOLASE)|DYNT (dynatronics.com) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Paragon 28 FNA|INVO Bioscience Inc. - Rasio rega marang pendapatan